Study Protocol for a Phase III Randomised Controlled Trial of Sailuotong (SLT) for Vascular Dementia and Alzheimer’s Disease with Cerebrovascular Disease
Diana Karamacoska, Daniel K.Y. Chan, Isabella Leung, Jian-xun Liu, View ORCID ProfileHenry Brodaty, View ORCID ProfilePaul P Fahey, Alan Bensoussan, View ORCID ProfileDennis H. Chang
doi: https://doi.org/10.1101/2022.03.24.22271670
Diana Karamacoska
1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
Daniel K.Y. Chan
1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
2South Western Sydney Clinical School, University of New South Wales, Kensington, NSW 2052, Australia
Isabella Leung
1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
Jian-xun Liu
3Research Center, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, China
Henry Brodaty
4Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Kensington, NSW 2052, Australia
Paul P Fahey
5School of Health Sciences, Western Sydney University, Penrith, NSW 2751, Australia
Alan Bensoussan
1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
Dennis H. Chang
1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
Posted March 27, 2022.
Study Protocol for a Phase III Randomised Controlled Trial of Sailuotong (SLT) for Vascular Dementia and Alzheimer’s Disease with Cerebrovascular Disease
Diana Karamacoska, Daniel K.Y. Chan, Isabella Leung, Jian-xun Liu, Henry Brodaty, Paul P Fahey, Alan Bensoussan, Dennis H. Chang
medRxiv 2022.03.24.22271670; doi: https://doi.org/10.1101/2022.03.24.22271670
Study Protocol for a Phase III Randomised Controlled Trial of Sailuotong (SLT) for Vascular Dementia and Alzheimer’s Disease with Cerebrovascular Disease
Diana Karamacoska, Daniel K.Y. Chan, Isabella Leung, Jian-xun Liu, Henry Brodaty, Paul P Fahey, Alan Bensoussan, Dennis H. Chang
medRxiv 2022.03.24.22271670; doi: https://doi.org/10.1101/2022.03.24.22271670
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12859)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4663)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2963)
- Health Policy (1078)
- Hematology (394)
- HIV/AIDS (940)
- Medical Education (432)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4448)
- Nursing (239)
- Nutrition (653)
- Oncology (2313)
- Ophthalmology (657)
- Orthopedics (260)
- Otolaryngology (329)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7044)
- Radiology and Imaging (1561)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (388)
- Surgery (495)
- Toxicology (60)
- Transplantation (213)
- Urology (186)